“Once we saw the potential of the difference it could make, we all felt obligated that we had to do something,” said David Richardson, co-founder and CEO of bioSyntagma LLC, a spinout of ASU. “If we didn’t do anything with the idea and make it a business, it would help no one.”
Read story here.
